GPCB orders closure of Piramal Pharma Dahej plant; firm to challenge in Gujarat High Court
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.8 pts less than Nifty Smallcap 250 and 1.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
On February 3, 2026, the Gujarat Pollution Control Board issued a notice directing Piramal Pharma to close its Dahej plant in Bharuch within 48 hours, citing alleged violations under Section 33-A of the Water (Prevention and Control of Pollution) Act, 1974. GPCB also demanded a bank guarantee of Rs 15 lakh with one-year validity. The company has called the allegations unsubstantiated and is filing an urgent Writ Petition in the Gujarat High Court to reverse the closure order. Financial and operational impact is currently not ascertainable.
Dahej plant shutdown risk may hit production and revenue. Company challenging order in court but outcome and timeline remain uncertain, likely causing near-term stock volatility.